Navigation Links
Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform
Date:3/5/2015

WHIPPANY, N.J., March 5, 2015 /PRNewswire/ -- Bayer HealthCare announced today that it has contributed one million dollars to the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) to support CancerLinQ™, a cutting edge health information technology platform designed to unlock vast quantities of information about the experiences of people living with cancer. 

"Bayer is proud to join ASCO and the Conquer Cancer Foundation in their efforts to leverage Big Data to help people whose lives have been affected by cancer," said Svetlana Kobina, MD, PhD, Head of Global Medical Affairs, Oncology, Bayer HealthCare.  "CancerLinQ is exciting in its potential to transform the future of cancer care through its ability to generate greater insights about patients living with cancer.  This information can potentially help capture valuable data about quality of life during drug development."

The CancerLinQ system will provide insights needed to help increase understanding of the needs of cancer patients and their caregivers. The insights collected will ultimately contribute to high-quality, personalized cancer care for every patient. 

"We are grateful for Bayer HealthCare's support of CancerLinQ, which aims to rapidly improve the overall quality of cancer care," said ASCO President Peter Paul Yu, MD, FACP, FASCO. "Instead of learning from only the three percent of cancer patients who participate in clinical trials, CancerLinQ will allow oncologists to learn from almost every patient."

For additional information about CancerLinQ, please visit http://CancerLinQ.org.

Bayer has a long-standing commitment to ASCO and the Conquer Cancer Foundation's mission of seeking advances in the prevention and treatment of cancer.

About Oncology at Bayer 
Bayer is committed to delivering Science for a Better Life by advancing a portfolio of innovative treatments. The oncology franchise at Bayer now includes three oncology products and several other compounds in various stages of clinical development. Together, these products reflect the company's approach to research, which prioritizes targets and pathways with the potential to impact the way that cancer is treated.

About Bayer HealthCare Pharmaceuticals 
Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG. Bayer HealthCare is one of the world's leading, innovative companies in the healthcare and medical products industry, and combines the activities of the Animal Health, Consumer Care, Medical Care, and Pharmaceuticals divisions.  As a specialty pharmaceutical company, Bayer HealthCare Pharmaceuticals Inc. provides products for General Medicine, Hematology, Neurology, Oncology and Women's Healthcare. The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

© 2015 Bayer HealthCare Pharmaceuticals Inc. 
BAYER and the Bayer Cross are registered trademarks of Bayer.               

Forward-Looking Statement 
This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 

PP-700-US-0033

Intended for U.S. Media Only

Logo - http://photos.prnewswire.com/prnh/20140312/NY79226LOGO

 


'/>"/>
SOURCE Bayer HealthCare
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Accepts Bayers Biologics License Application for Investigational Treatment Option in Hemophilia A
2. Global POC Diagnostics Market 2015-2019 with Abbott Labs, Alere, Bayer Healthcare, Danaher, F. Hoffmann-La Roche & Johnson & Johnson Dominating
3. Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong
4. Bayer HealthCare and Aronora Establish Partnership for the Pre-Clinical Manufacturing of AB-022
5. Bayer Presents Latest Oncology Research at ASCO GU 2015
6. Bayer Healthcare Expands Patient Assistance Program To Include An Additional Intrauterine Device At No Cost To Women Who Qualify
7. A new twist on a traditional medical instrument: Innovative single-use torque instruments utilize tough polycarbonate from Bayer
8. Bayer launches new polycarbonate blend grade tailored for wearable medical devices
9. Prescription for improved IV pole: Innovative IV pole utilizing polycarbonate resin blend from Bayer enhances patient and health care worker safety
10. Bayer materials withstand demanding conditions and meet requirements for innovative medical devices
11. Statement from Phillip Blake, President of Bayer Corporation, on FDA Commissioner Margaret Hamburg, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2020)... ... June 24, 2020 , ... The Safe Boating Campaign, a ... July. Boating under the influence, or BUI, is the leading contributing factor in recreational ... around the corner, and unfortunately has become known for drinking and boating, and deadly ...
(Date:6/23/2020)... BETHESDA, Md. (PRWEB) , ... June 23, 2020 ... ... with DisasterReady.org to launch one of the first online COVID-19 trainings ... of the eight courses in this free training entitled COVID-19 Training for ...
(Date:6/23/2020)... ... 2020 , ... Draper today announced the release of a ... test an in vitro human lung model to investigate responses following infection with ... and the University of Massachusetts Medical School . The manuscript, titled ...
Breaking Medicine Technology:
(Date:6/28/2020)... ... June 26, 2020 , ... The ... the general public. As a supplier of top-quality masks, sanitizers and thermometers, Trusted ... PPE equipment. President Priya Agarwal observed, “All of our masks are manufactured to ...
(Date:6/25/2020)... ... June 25, 2020 , ... ... in KLAS Overall IT Services Firm, expanded its telehealth services to ... by seasoned telehealth expert and a Consulting Magazine “2020 Women Leaders in Technology” ...
(Date:6/24/2020)... ... 2020 , ... Dr. Katinka van der Merwe, the creator of the world’s ... True Grit and Grace podcast. She explains her outside-the-box, holistic approach to treating CRPS ... , After being diagnosed with CRPS about 10 years ago, Amberly Lago , ...
(Date:6/24/2020)... ... June 24, 2020 , ... Dr. Keith Chertok, ... lip ties and tongue ties as well as sleep-disordered breathing. Recently completing a ... care with multispecialty teams including myofunctional therapists and sleep surgeons. , The Breathe ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... in increasing revenue for hospitals and specialty physician practices from international healthcare ... vertical payments company. , The partnership will enable Sunbelt Health Partners to ...
Breaking Medicine News(10 mins):